Corpus Intelligence IC Memo — NORTHWEST MEDICAL CENTER 2026-04-26 09:34 UTC
IC Memo — NORTHWEST MEDICAL CENTER
Investment Committee Memorandum | AL | 28 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NORTHWEST MEDICAL CENTER

CCN 010086 | MARION, AL | 28 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

NORTHWEST MEDICAL CENTER is a 28-bed rural/critical access in MARION, AL with $23.8M in net patient revenue and a -12.1% operating margin. The hospital serves a payer mix of 44.1% Medicare, 9.9% Medicaid, and 46.1% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.1% to -4.7% (+736bps).

Net Revenue HCRIS$23.8M
Current EBITDA COMPUTED$-2.9M
Operating Margin COMPUTED-12.1%
Occupancy HCRIS34.7%
Revenue / Bed COMPUTED$850K
Net-to-Gross HCRIS20.0%
Distress Probability ML53.0%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
55
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -12.1% places it below the state median. Among 55 size-comparable peers (14-56 beds), the median margin is -16.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-56), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NORTHWEST MEDICAL CENTER (Target)AL28$23.8M-12.1%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
NORTH BALDWIN INFIRMARYAL35$55.3M-3.3%
PRATTVILLE BAPTIST HOSPITALAL55$53.5M-16.2%
HIGHLANDS MEDICAL CENTERAL45$45.9M-30.2%
ST. VINCENTS ST. CLAIRAL40$40.8M8.7%
TROY REGIONAL MEDICAL CENTERAL41$39.0M-9.1%
WHITFIELD REGIONAL HOSPITALAL47$38.7M-21.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$500K+210bp18mo
Cost to Collect4.5%2.5%$476K+200bp12mo
Denial Rate Reduction12.0%6.5%$471K+198bp12mo
A/R Days Reduction5200.0%3800.0%$290K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$500K
Cost to Collect
$476K
Denial Rate Reduction
$471K
A/R Days Reduction
$290K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$-2.9M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$-1.1M
Current Margin-12.1%
Pro Forma Margin-4.7%
WC Released (1x)$913K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.4M$-1.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.4M$-3.0M0.00x-100.0%
Bull Case9.0x11.0x$-4.0M$1.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.0M$239K0.00x-100.0%
Bear Case11.0x10.0x$-4.9M$-8.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.9M$-11.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 34.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 53.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 14-56 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-27.9% / P50=-16.0% / P75=-2.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.